Matthew C Riddle

Matthew C Riddle

UNVERIFIED PROFILE

Are you Matthew C Riddle?   Register this Author

Register author
Matthew C Riddle

Matthew C Riddle

Publications by authors named "Matthew C Riddle"

Are you Matthew C Riddle?   Register this Author

100Publications

1756Reads

10Profile Views

The Cardiovascular Legacy of Good Glycemic Control: Clues About Mediators From the DCCT/EDIC Study.

Diabetes Care 2019 Jul;42(7):1159-1161

Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci19-0023DOI Listing
July 2019

More Evidence for a Prevention-Related Indication for Metformin: Let the Arguments Resume!

Diabetes Care 2019 04;42(4):499-501

Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci18-0062DOI Listing
April 2019

in 2019-Who, Why, What, and How?

Authors:
Matthew C Riddle

Diabetes Care 2019 02;42(2):181-182

Division of Endocrinology, Diabetes, & Clinical Nutrition, Oregon Health & Science University, Portland, OR

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci18-0059DOI Listing
February 2019

SGLT Inhibitors for Type 1 Diabetes: An Obvious Choice or Too Good to Be True?

Diabetes Care 2018 12;41(12):2444-2447

American Diabetes Association, Arlington, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci18-0041DOI Listing
December 2018

Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?

Diabetes Care 2018 08 25;41(8):1560-1562. Epub 2018 Jun 25.

Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci18-0025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054497PMC
August 2018

The Cost of Diabetes Care-An Elephant in the Room.

Diabetes Care 2018 05;41(5):929-932

University of Michigan Schools of Medicine and Public Health, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci18-0012DOI Listing
May 2018

Scientific Exploration With Continuous Monitoring Systems: An Early Assessment of Arrhythmias During Hypoglycemia.

Diabetes Care 2018 04;41(4):664-666

Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC.

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/lookup/doi/10.2337/dci18-00
Publisher Site
http://dx.doi.org/10.2337/dci18-0009DOI Listing
April 2018

Insulin resistance and cardiovascular outcomes in the ORIGIN trial.

Diabetes Obes Metab 2018 03 8;20(3):564-570. Epub 2017 Oct 8.

Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13112DOI Listing
March 2018

In an Anniversary Year, Takes a Selfie.

Authors:
Matthew C Riddle

Diabetes Care 2018 01;41(1):3-5

Division of Endocrinology, Diabetes, & Clinical Nutrition, Oregon Health & Science University, Portland, OR

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci17-0054DOI Listing
January 2018

Diabetes Research and Care Through the Ages.

Diabetes Care 2017 10;40(10):1302-1313

CNR Institute of Clinical Physiology, and the Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci17-0042DOI Listing
October 2017

Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.

Circulation 2017 10;136(16):1560-1562

From Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.W., B.C., E.F.L., S.D.S., M.A.P.); Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (E.W., L.K.); Estudios Clínicos Latinoamérica, Rosario, Argentina (R.D.); University of Bergen, Stavanger University Hospital, Norway (K.D.); Division of Endocrinology & Metabolism, McMaster University, Hamilton, Ontario, Canada (H.C.G.); Sanofi US, Bridgewater, NJ (F.C.L.); Research Center of the Italian Association of Hospital Cardiologists, Florence, Italy (A.P.M.); British Heart Foundation Cardiovascular Research Centre, University of Glasgow, United Kingdom (J.J.V.M.); Division of Cardiology, University of Washington Medical Center, Seattle (J.L.P.); Division of Endocrinology, Oregon Health and Science University, Portland (M.C.R.); and Montreal Heart Institute, Université de Montréal, Quebec, Canada (J.-C.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.029503DOI Listing
October 2017

Human Insulin for Type 2 Diabetes: An Effective, Less-Expensive Option.

JAMA 2017 07;318(1):23-24

Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health & Science University, Portland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2017.6939DOI Listing
July 2017

Modern Sulfonylureas: Dangerous or Wrongly Accused?

Authors:
Matthew C Riddle

Diabetes Care 2017 05;40(5):629-631

Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci17-0003DOI Listing
May 2017

Basal Glucose Can Be Controlled, but the Prandial Problem Persists-It's the Next Target!

Authors:
Matthew C Riddle

Diabetes Care 2017 Mar;40(3):291-300

Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc16-2380DOI Listing
March 2017

Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory".

Diabetes Care 2016 05;39(5):664-7

Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc16-0405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013718PMC
May 2016

Lessons From Peglispro: IMAGINE How to Improve Drug Development and Affordability.

Authors:
Matthew C Riddle

Diabetes Care 2016 04;39(4):499-501

Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc15-2754DOI Listing
April 2016

Insulin's Role in Diabetes Management: After 90 Years, Still Considered the Essential "Black Dress".

Diabetes Care 2015 Dec;38(12):2200-3

Division of Endocrinology, Diabetes & Clinical Nutrition, Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci15-0023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657614PMC
December 2015

Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.

N Engl J Med 2015 Dec;373(23):2247-57

From the Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School - both in Boston (M.A.P., B.C., E.F.L., S.D.S.); Estudios Clínicos Latinoamérica, Rosario, Argentina (R.D.); University of Bergen, Stavanger University Hospital, Stavanger, Norway (K.D.); McMaster University, Hamilton, ON, Canada (H.C.G.); Rigshospitalet Copenhagen University Hospital, Copenhagen (L.V.K.); Sanofi U.S., Bridgewater, NJ (F.C.L., L.P., X.W.); Research Center of the Italian Association of Hospital Cardiologists, Florence (A.P.M.); British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (J.J.V.M.); University of Washington Medical Center, Seattle (J.L.P.); Oregon Health and Science University, Portland (M.C.R.); and Montreal Heart Institute, Université de Montréal, Montreal (J.C.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1509225DOI Listing
December 2015

Comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074.

Diabetes Care 2015 Oct;38(10):e170-1

Population Health Research Institute and McMaster University, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc15-1073DOI Listing
October 2015

Diabetes: Controlling glucose levels in elderly people--benefits versus risks.

Authors:
Matthew C Riddle

Nat Rev Endocrinol 2015 May 24;11(5):257-8. Epub 2015 Feb 24.

Oregon Health &Sciences University, L-345, 3181 SW Sam Jackson Park Road, Portland, OR 97239-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2015.23DOI Listing
May 2015

SGLT2 inhibitors: the latest "new kids on the block"!

Diabetes Care 2015 Mar;38(3):352-4

Oregon Health & Science University, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-3048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131877PMC
March 2015

Welcome reassurance about GLP-1 drugs--but they are still young and not fully grown.

Authors:
Matthew C Riddle

Diabetes Care 2015 Feb;38(2):183-5

Division of Endocrinology, Diabetes & Clinical Nutrition, Department of Medicine, Oregon Health & Science University, Portland, OR

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc14-2649DOI Listing
February 2015

Learning about new therapies: phase 3 clinical studies--and beyond.

Authors:
Matthew C Riddle

Diabetes Care 2013 Sep;36(9):2453-5

Section of Diabetes, Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health & Science University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc13-1019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747890PMC
September 2013

Contributions of basal and prandial hyperglycemia to total hyperglycemia in older and younger adults with type 2 diabetes mellitus.

J Am Geriatr Soc 2013 Apr 21;61(4):535-41. Epub 2013 Mar 21.

Beth Israel Deaconess Medical Center, Joslin Diabetes Center, and Harvard Medical School, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.12167DOI Listing
April 2013

Individualizing targets and tactics for high-risk patients with type 2 diabetes: practical lessons from ACCORD and other cardiovascular trials.

Diabetes Care 2012 Oct;35(10):2100-7

Division of Endocrinology, Diabetes, & Clinical Nutrition, Oregon Health & Science University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc12-0650DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447843PMC
October 2012

Meta-Analysis of Maternal and Neonatal Outcomes Associated with the Use of Insulin Glargine versus NPH Insulin during Pregnancy.

Obstet Gynecol Int 2012 16;2012:649070. Epub 2012 May 16.

Service de Gynécologie-Obstétrique, Hôpital Cochin-Saint Vincent de Paul, Cedex 14, 75674 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/649070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362948PMC
August 2012

Relationship between A1C and fasting plasma glucose in dysglycemia or type 2 diabetes: an analysis of baseline data from the ORIGIN trial.

Diabetes Care 2012 Apr 8;35(4):749-53. Epub 2012 Feb 8.

India Diabetes Research Foundation and Dr. A. Ramachandran’s Diabetes Hospitals, Chennai, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc11-1918DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308289PMC
April 2012

Reevaluating goals of insulin therapy: perspectives from large clinical trials.

Endocrinol Metab Clin North Am 2012 Mar 5;41(1):41-56. Epub 2012 Apr 5.

Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Medicine, Oregon Health and Science University, 3181 Southwest Sam Jackson Park Road, Mailcode L345, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2012.03.003DOI Listing
March 2012

Glycemic control and cardiovascular mortality.

Authors:
Matthew C Riddle

Curr Opin Endocrinol Diabetes Obes 2011 Apr;18(2):104-9

Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health & Science University, Portland, Oregon 97239-3098, USA.

View Article

Download full-text PDF

Source
http://circ.ahajournals.org/content/120/24/2421.full.pdf
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MED.0b013e3283446b7eDOI Listing
April 2011

Counterpoint: Intensive glucose control and mortality in ACCORD--still looking for clues.

Authors:
Matthew C Riddle

Diabetes Care 2010 Dec;33(12):2722-4

Oregon Health & Science University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc10-1658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992221PMC
December 2010

Therapy: What evidence should guide the use of thiazolidinediones?

Authors:
Matthew C Riddle

Nat Rev Endocrinol 2010 Nov;6(11):600-2

Oregon Health & Science University, Division of Endocrinology, Diabetes & Clinical Nutrition L-345, 3181 Southwest Sam Jackson Park Road, Portland, OR 97239-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2010.156DOI Listing
November 2010

More reasons to say goodbye to glyburide.

Authors:
Matthew C Riddle

J Clin Endocrinol Metab 2010 Nov;95(11):4867-70

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2010-1972DOI Listing
November 2010

Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:
Matthew C Riddle

Circulation 2010 Aug;122(8):844-6

Oregon Health and Science University, L-345, 3181 SW Sam Jackson Park Rd, Portland, OR 97239-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.110.960138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980502PMC
August 2010

Starting and advancing insulin for type 2 diabetes: algorithms and individualized methods are both necessary.

Authors:
Matthew C Riddle

J Clin Endocrinol Metab 2008 Feb 11;93(2):372-4. Epub 2007 Dec 11.

Division of Endocrinology, Diabetes, & Clinical Nutrition, Oregon Health & Science University L-345, Portland, Oregon 97239-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2007-2576DOI Listing
February 2008

Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor.

Authors:
Matthew C Riddle

Diabetes Care 2008 Feb;31 Suppl 2:S125-30

Section of Diabetes L-345, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Portland, OR 97201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc08-s231DOI Listing
February 2008

Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Am J Cardiol 2007 Jun 19;99(12A):34i-43i. Epub 2007 Apr 19.

Department of Medicine and the Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000291490700439
Publisher Site
http://dx.doi.org/10.1016/j.amjcard.2007.03.004DOI Listing
June 2007

The Treat-to-Target Trial and related studies.

Authors:
Matthew C Riddle

Endocr Pract 2006 Jan-Feb;12 Suppl 1:71-9

Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health and Sciences University, Portland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4158/EP.12.S1.71DOI Listing
May 2006

Is initial combination therapy effective in the treatment of type 2 diabetes?

Authors:
Matthew C Riddle

Nat Clin Pract Endocrinol Metab 2006 May;2(5):254-5

Division of Endocrinology, Diabetes and Clinical Nutrition, Oregon Health and Sciences University, Portland, 97239-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpendmet0167DOI Listing
May 2006

Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1.

Diabetes Care 2006 Feb;29(2):435-49

Section of Diabetes, Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diacare.29.02.06.dc05-1267DOI Listing
February 2006

Making the transition from oral to insulin therapy.

Authors:
Matthew C Riddle

Am J Med 2005 May;118 Suppl 5A:14S-20S

Section of Diabetes, Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, Portland, Oregon 97201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2005.04.008DOI Listing
May 2005

Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations.

Authors:
Matthew C Riddle

Endocrinol Metab Clin North Am 2005 Mar;34(1):77-98

Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University, 3181 SW Sam Jackson Park Drive, Portland, OR 97239-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ecl.2004.12.002DOI Listing
March 2005

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes.

Diabetes Care 2005 Feb;28(2):254-9

Zentralkrankenhaus, Bremen-Nord, II Medizinische Abteilung, Hammersbecker Str. 228, 28755 Bremen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diacare.28.2.254DOI Listing
February 2005

Type 2 diabetes: the role of basal insulin therapy.

J Fam Pract 2004 Mar;53(3):215-22

View Article

Download full-text PDF

Source
March 2004

Timely initiation of basal insulin.

Authors:
Matthew C Riddle

Am J Med 2004 Feb;116 Suppl 3A:3S-9S

Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2003.12.003DOI Listing
February 2004

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Diabetes Care 2003 Nov;26(11):3080-6

Oregon Health and Science University, Portland, Oregon 97201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diacare.26.11.3080DOI Listing
November 2003

The underuse of insulin therapy in North America.

Authors:
Matthew C Riddle

Diabetes Metab Res Rev 2002 Sep-Oct;18 Suppl 3:S42-9

Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health Sciences University, Portland, OR 97201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dmrr.277DOI Listing
April 2003

Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?

Authors:
Matthew C Riddle

J Clin Endocrinol Metab 2003 Feb;88(2):528-30

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2002-021971DOI Listing
February 2003

Current oral agents for type 2 diabetes. Many options, but which to choose when?

Postgrad Med 2002 May;111(5):32-4, 37-40, 43-6

Division of Endocrinology, Diabetes, and Clinical Nutrition, Oregon Health and Science University School of Medicine, 3181 SW Sam Jackson Park Rd, OP05, Portland, OR 97201-3098, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3810/pgm.2002.05.1194DOI Listing
May 2002